Genes of Hypertension in African Americans

This study has been completed.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Theodore Kotchen, MD, Medical College of Wisconsin
ClinicalTrials.gov Identifier:
NCT00063505
First received: June 30, 2003
Last updated: April 22, 2014
Last verified: April 2014
  Purpose

To identify genes contributing to hypertension in African Americans by focusing on the physiological pathways that determine arterial pressure.


Condition
Cardiovascular Diseases
Heart Diseases
Hypertension

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Cross-Sectional
Official Title: Genes of Hypertension in African Americans

Resource links provided by NLM:


Further study details as provided by Medical College of Wisconsin:

Primary Outcome Measures:
  • genes of hypertension in African Americans [ Time Frame: One time data collection ] [ Designated as safety issue: No ]
    There is no intervention


Biospecimen Retention:   Samples With DNA

Blood cells and DNA


Enrollment: 5000
Study Start Date: December 2002
Study Completion Date: July 2008
Primary Completion Date: July 2008 (Final data collection date for primary outcome measure)
Detailed Description:

BACKGROUND:

Since the mid 1990s, the investigators have extensively characterized African Americans for phenotypes related to cardiovascular and renal function. Based on recently completed genome scans, they have identified several chromosomal regions likely to contain genes influencing hypertension-related phenotypes in hypertensive, African American sib pairs. For several phenotypes, overlapping QTLs have also been identified in related studies in a genetically isolated French Canadian population and/or in homologous chromosomal regions in the F2 cross of Dahl-salt sensitive x normotensive Brown Norway rats.

DESIGN NARRATIVE:

The investigators will extensively phenotype 500 hypertensive and 500 normotensive African American subjects to conduct a genetic association study, using a single nucleotide polymorphism (SNP) genomic scan approach. To achieve a clear separation of blood pressures from hypertensive subjects, normotensive subjects will be selected from the lower third of the population-based blood pressure distribution. Hypertensive (BMI), and age. Inclusion of phenotypes is based on their relevance to the pathophysiology of hypertension and prior evidence of "heritability." Candidate genes for SNP analysis will be selected within chromosomal regions of two quantitative trait loci (QTLs) that they have previously demonstrated to be linked to hypertension-related phenotypes--a QTL for body mass index on chromosome 1 and a QTL for microalbuminuria on chromosome 18. SNP analyses will be carried out in 15 percent of the genes within each of these QTLs, and genes will be selected on the basis of their relevance to hypertension, including documented sequence conservation for blood pressure related QTLs with rat or mouse. The final goal of the project is to determine if distinct clusters of blood pressure related phenotypes can be identified that will permit stratification of hypertensive individuals into distinct subgroups to facilitate the analysis of the genetic determinants of hypertension and/or provide mechanistic leads to genes contributing to these traits.

  Eligibility

Ages Eligible for Study:   18 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

African Americans

Criteria

African Americans, age 18-75 years

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00063505

Sponsors and Collaborators
Medical College of Wisconsin
Investigators
Principal Investigator: Theodore Kotchen Medical College of Wisconsin
  More Information

Publications:
Responsible Party: Theodore Kotchen, MD, Professor, Asssociate Dean for Clinical Research, Medical College of Wisconsin
ClinicalTrials.gov Identifier: NCT00063505     History of Changes
Other Study ID Numbers: 1216, R01HL070111
Study First Received: June 30, 2003
Last Updated: April 22, 2014
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Hypertension
Cardiovascular Diseases
Heart Diseases
Vascular Diseases

ClinicalTrials.gov processed this record on September 30, 2014